# Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke

Study · id `cardio:ct-nct01862978` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT01862978](<https://clinicaltrials.gov/study/NCT01862978>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT01862978

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 150 participants.

## Technical summary

Registry record NCT01862978. Randomized; quadruple masking; primary purpose treatment. Start 2013-05 (registry gives no type); primary completion 2015-05 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 4
- Enrolled: 150 participants (planned count; ClinicalTrials.gov record NCT01862978, source copy `cardio:ctgov-nct01862978-2013-08-15`, retrieved 2026-10-26)
- Start date: 2013-05 (registry gives no type) (ClinicalTrials.gov record NCT01862978, source copy `cardio:ctgov-nct01862978-2013-08-15`, retrieved 2026-10-26)
- Primary completion: 2015-05 (anticipated) (ClinicalTrials.gov record NCT01862978, source copy `cardio:ctgov-nct01862978-2013-08-15`, retrieved 2026-10-26)
- Completion: 2015-12 (anticipated) (ClinicalTrials.gov record NCT01862978, source copy `cardio:ctgov-nct01862978-2013-08-15`, retrieved 2026-10-26)
- Countries: Slovakia (ClinicalTrials.gov record NCT01862978, source copy `cardio:ctgov-nct01862978-2013-08-15`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct01862978-2013-08-15`, retrieved 2026-10-26)

## The registry's words

- Brief title: Safety and Efficacy of Heparin and Nadroparin in the Acute Phase of Ischemic Stroke
- Acronym: Heparinas
- Condition: Acute Ischemic Stroke
- Intervention (Drug): Heparin
- Intervention (Drug): Nadroparin
- Intervention (Drug): Placebo
- Lead sponsor: University Hospital, Martin
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Ischemic stroke (`cardio:ischemic-stroke`)
- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry intervention name matches this record: Heparin (`cardio:heparin`)
- Registry lists this organization as the lead sponsor: University Hospital, Martin (`cardio:org-university-hospital-martin`)

### Other papers using this trial's data

- Registry lists this paper as a derived reference; the paper's PubMed record names this trial's registry number and no other, PubMed types it as a trial report dated on or after the primary completion, neither its types nor its title mark it as a protocol, a design, an observational study or work outside the trial's own data, and PubMed shows no retraction or expression of concern: The safety and efficacy of Heparin and Nadroparin compared to placebo in acute ischemic stroke - pilot study (`cardio:pubmed-27646496`)

Courtesy of the U.S. National Library of Medicine.

## Provenance

Content hash: 5671fdaaf80f12a7a0c30eeba16ef9167c7e87a091615e9fc53acfcbf1db7607
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
